Package 51672-4045-3

{"route": ["ORAL"], "spl_id": "1130a62d-94e3-2dc6-e063-6394a90a8a67", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "9O25354EPJ"], "rxcui": ["858824", "858828"], "spl_set_id": ["7cb92cf2-46f2-4379-937c-168d230e43a4"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51672-4045-1)", "package_ndc": "51672-4045-1", "marketing_start_date": "20010918"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (51672-4045-3)", "package_ndc": "51672-4045-3", "marketing_start_date": "20010918"}], "brand_name": "Enalapril Maleate and Hydrochlorothiazide", "product_id": "51672-4045_1130a62d-94e3-2dc6-e063-6394a90a8a67", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "51672-4045", "generic_name": "Enalapril Maleate and Hydrochlorothiazide", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Enalapril Maleate and Hydrochlorothiazide", "active_ingredients": [{"name": "ENALAPRIL MALEATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}], "application_number": "ANDA075788", "marketing_category": "ANDA", "marketing_start_date": "20010918", "listing_expiration_date": "20261231"}